HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Spliceosome-Targeted Therapies Induce dsRNA Responses.

Abstract
In a recent issue of Cell, Bowling et al. describe a mechanism by which spliceosome-targeted therapies result in intron-containing transcripts that form double-stranded RNAs (dsRNAs), thereby activating tumor antiviral signaling (viral mimicry) and downstream adaptive immunity.
AuthorsCharles A Ishak, Helen Loo Yau, Daniel D De Carvalho
JournalImmunity (Immunity) Vol. 54 Issue 1 Pg. 11-13 (01 12 2021) ISSN: 1097-4180 [Electronic] United States
PMID33440135 (Publication Type: Journal Article, Comment)
CopyrightCopyright © 2020 Elsevier Inc. All rights reserved.
Chemical References
  • Antiviral Agents
  • RNA, Double-Stranded
Topics
  • Adaptive Immunity
  • Antiviral Agents (pharmacology)
  • RNA, Double-Stranded
  • Signal Transduction (drug effects)
  • Spliceosomes

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: